ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 64 filers reported holding ONCOCYTE CORP in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,000 | -30.8% | 5,847 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -38.1% | 5,847 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -47.5% | 5,847 | -15.2% | 0.00% | – |
| Q2 2021 | $40,000 | -2.4% | 6,896 | -12.5% | 0.00% | – |
| Q1 2021 | $41,000 | +127.8% | 7,877 | +4.4% | 0.00% | – |
| Q4 2020 | $18,000 | +80.0% | 7,545 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -28.6% | 7,545 | +6.4% | 0.00% | – |
| Q2 2020 | $14,000 | +100.0% | 7,094 | +143.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 2,919 | -32.7% | 0.00% | – |
| Q4 2019 | $9,000 | +28.6% | 4,339 | +21.3% | 0.00% | – |
| Q3 2019 | $7,000 | -22.2% | 3,576 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | +800.0% | 3,576 | +831.2% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 384 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -87.5% | 384 | -81.8% | 0.00% | – |
| Q3 2017 | $16,000 | +45.5% | 2,115 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | – | 2,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |